Envision Healthcare Corporation is a provider of healthcare services. The Company offers a range clinical solutions, including physician-led services, medical transportation, ambulatory services and post-acute services. The Company operates through three segments: physician services, medical transportation and ambulatory services. The physician services segment includes the Company's hospital-based and non-hospital-based physician services business. The medical transportation segment includes the Company's community-based medical transportation services, including emergency 911, non-emergency, managed transportation, air ambulance and disaster response services. The ambulatory services segment includes the Company's ambulatory surgery business, which acquires, develops, owns and operates ambulatory surgery centers (ASCs) and surgical hospitals in partnership with physicians and health systems.
Industry, Sector and Symbol:
- Sector: Healthcare
- Industry: Hospitals, Clinics & Primary Care Services
- Sub-Industry: Health Care Facilities
- Symbol: NASDAQ:AMSG
- CUSIP: 03232P40
- Web: www.amsurg.com
- 50 Day Moving Avg: $64.49
- 200 Day Moving Avg: $69.95
- 52 Week Range: $57.32 - $84.71
- Trailing P/E Ratio: N/A
- Foreward P/E Ratio: 13.97
- P/E Growth: 0.00
- Net Margins: 4.64%
- Return on Equity: 1.89%
- Return on Assets: 2.09%
- Debt-to-Equity Ratio: 0.93%
- Current Ratio: 1.65%
- Quick Ratio: 1.59%
- Average Volume: 1.59 million shs.
- Beta: 0.72
Frequently Asked Questions for Envision Healthcare Corp (NASDAQ:AMSG)
What is Envision Healthcare Corp's stock symbol?
Envision Healthcare Corp trades on the NASDAQ under the ticker symbol "AMSG."
How were Envision Healthcare Corp's earnings last quarter?
Envision Healthcare Corp (NASDAQ:AMSG) released its quarterly earnings results on Tuesday, August, 2nd. The company reported $1.10 EPS for the quarter, topping the Thomson Reuters' consensus estimate of $1.08 by $0.02. The business had revenue of $758.50 million for the quarter, compared to analysts' expectations of $769.88 million. Envision Healthcare Corp had a return on equity of 1.89% and a net margin of 4.64%. The company's revenue was up 21.5% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.97 earnings per share. View Envision Healthcare Corp's Earnings History.
Where is Envision Healthcare Corp's stock going? Where will Envision Healthcare Corp's stock price be in 2017?
6 brokerages have issued 12-month target prices for Envision Healthcare Corp's stock. Their predictions range from $71.00 to $101.00. On average, they expect Envision Healthcare Corp's share price to reach $85.60 in the next year. View Analyst Ratings for Envision Healthcare Corp.
Who are some of Envision Healthcare Corp's key competitors?
Some companies that are related to Envision Healthcare Corp include Mediclinic International PLC (MDC), Premier (PINC), AMN Healthcare Services (AMN), Healthways (TVTY), Spire Healthcare Group PLC (SPI), The Ensign Group (ENSG), Surgery Partners (SGRY), U.S. Physical Therapy (USPH), BioScrip (BIOS), AAC Holdings (AAC), Quorum Health Corp (QHC) and Mediclinic International PLC (ANH).
Who are Envision Healthcare Corp's key executives?
Envision Healthcare Corp's management team includes the folowing people:
- William A. Sanger, Executive Chairman of the Board
- Christopher A. Holden, President, Chief Executive Officer, Director
- Claire M. Gulmi, Chief Financial Officer, Executive Vice President
- Robert J. Coward, Executive Vice President and President — Physician Services Group
- Randel G. Owen, Executive Vice President and President — Ambulatory Services Group
- Kevin Delon Eastridge, Senior Vice President, Chief Accounting Officer
- Craig A. Wilson, Senior Vice President, General Counsel, Secretary
- Carol J. Burt, Director
- Cynthia S. Miller, Director
- James A. Deal, Independent Director
How do I buy Envision Healthcare Corp stock?
Shares of Envision Healthcare Corp can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Envision Healthcare Corp's stock price today?
MarketBeat Community Rating for Envision Healthcare Corp (NASDAQ AMSG)MarketBeat's community ratings are surveys of what our community members think about Envision Healthcare Corp and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
One share of Envision Healthcare Corp stock can currently be purchased for approximately $67.75.
Consensus Ratings for Envision Healthcare Corp (NASDAQ:AMSG) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||1 Hold Rating, 5 Buy Ratings|
|Consensus Rating:||Buy (Score: 2.83)|
|Consensus Price Target: ||$85.60 (26.35% upside)|
Analysts' Ratings History for Envision Healthcare Corp (NASDAQ:AMSG)
(Data available from 7/21/2015 forward)
|Date||Firm||Action||Rating||Price Target||Impact on Share Price||Details|
|12/1/2016||Robert W. Baird||Set Price Target||Buy||$101.00||N/A|
|11/9/2016||Mizuho||Downgrade||Buy -> Neutral||$95.00 -> $71.00||N/A|
|11/2/2016||Cantor Fitzgerald||Set Price Target||Buy||$90.00||N/A|
|11/2/2016||Wells Fargo & Company||Upgrade||Market Perform -> Outperform||N/A|
|9/26/2016||Citigroup Inc.||Initiated Coverage||Buy||$64.78 -> $79.00||N/A|
|7/3/2016||Jefferies Group LLC||Reiterated Rating||Buy||N/A|
|6/17/2016||Goldman Sachs Group, Inc. (The)||Reiterated Rating||Buy||N/A|
|6/16/2016||Bank of America Corporation||Upgrade||Neutral -> Buy||$104.00||N/A|
|6/1/2016||Barclays PLC||Initiated Coverage||Equal Weight||$85.00||N/A|
|2/19/2016||Piper Jaffray Companies||Reiterated Rating||Buy||$90.00 -> $86.00||N/A|
|9/16/2015||J P Morgan Chase & Co||Initiated Coverage||Overweight||$94.00||N/A|
Earnings History for Envision Healthcare Corp (NASDAQ:AMSG)Earnings History by Quarter for Envision Healthcare Corp (NASDAQ AMSG)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|11/1/2016||Q3||$1.13||$1.13||$770.29 million||$822.20 million||View||Listen|
|8/2/2016||Q2||$1.08||$1.10||$769.88 million||$758.50 million||View||Listen|
|5/3/2016||Q1||$0.78||$0.82||$705.27 million||$724.70 million||View||Listen|
|2/24/2016||Q4||$1.03||$1.07||$684.16 million||$704.30 million||View||Listen|
|11/3/2015||Q3||$0.94||$1.03||$631.20 million||$650.20 million||View||Listen|
|8/4/2015||Q215||$0.84||$0.97||$614.37 million||$642.00 million||View||Listen|
|5/5/2015||Q115||$0.57||$0.62||$574.30 million||$570.45 million||View||Listen|
|2/25/2015||Q414||$0.73||$0.77||$565.30 million||$581.80 million||View||Listen|
|11/4/2014||Q314||$0.58||$0.69||$515.10 million||$503.20 million||View||Listen|
|7/31/2014||Q214||$0.63||$0.63||$281.51 million||$281.10 million||View||Listen|
|4/22/2014||Q114||$0.55||$0.53||$272.09 million||$263.11 million||View||Listen|
|2/25/2014||Q413||$0.57||$0.60||$283.54 million||$284.60 million||View||Listen|
|10/23/2013||Q313||$0.53||$0.53||$264.21 million||$268.20 million||View||Listen|
|7/23/2013||Q2 2013||$0.56||$0.58||$265.84 million||$269.30 million||View||Listen|
|4/23/2013||Q1 2013||$0.52||$0.52||$263.74 million||$260.10 million||View||Listen|
|2/25/2013||Q4 2012||$0.50||$0.49||$237.94 million||$244.20 million||View||Listen|
Earnings Estimates for Envision Healthcare Corp (NASDAQ:AMSG)
2017 EPS Consensus Estimate: $4.59
(Data provided by Zacks Investment Research)
|Quarter||Number of Estimates||Low Estimate||High Estimate||Average Estimate|
Dividend History for Envision Healthcare Corp (NASDAQ:AMSG)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for Envision Healthcare Corp (NASDAQ:AMSG)
Insider Ownership Percentage: 2.30%Insider Trades by Quarter for Envision Healthcare Corp (NASDAQ:AMSG)
Institutional Ownership Percentage: 98.67%
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|8/26/2016||Robert Jon Coward||Insider||Sell||7,500||$63.65||$477,375.00|| |
|8/18/2016||Robert Jon Coward||Insider||Sell||7,500||$64.36||$482,700.00|| |
|9/2/2015||Christopher A Holden||CEO||Sell||3,000||$77.00||$231,000.00|| |
|8/14/2015||Claire M Gulmi||CFO||Sell||15,000||$84.74||$1,271,100.00|| |
|6/3/2015||Christopher A Holden||CEO||Sell||3,000||$69.02||$207,060.00|| |
|5/5/2015||Christopher A Holden||CEO||Sell||3,000||$62.91||$188,730.00|| |
|4/6/2015||Christopher A Holden||CEO||Sell||3,000||$63.36||$190,080.00|| |
|3/26/2015||Kevin P Lavender||Director||Sell||2,500||$62.00||$155,000.00|| |
|3/24/2015||Claire M Gulmi||CFO||Sell||24,008||$64.18||$1,540,833.44|| |
|3/4/2015||Kevin Delon Eastridge||CAO||Sell||8,999||$60.43||$543,809.57|| |
|12/5/2014||David L Manning||EVP||Sell||5,000||$50.83||$254,150.00|| |
|11/20/2014||David L Manning||EVP||Sell||10,000||$50.61||$506,100.00|| |
|6/9/2014||David L Manning||EVP||Sell||12,380||$50.75||$628,285.00|| |
|6/3/2014||Christopher A Holden||CEO||Sell||3,000||$46.39||$139,170.00|| |
|5/5/2014||Christopher Holden||CEO||Sell||3,000||$42.04||$126,120.00|| |
|4/2/2014||David Manning||EVP||Sell||23,500||$48.55||$1,140,925.00|| |
|4/1/2014||Christopher Holden||CEO||Sell||3,000||$47.37||$142,110.00|| |
|3/5/2014||Christopher Holden||CEO||Sell||3,000||$45.05||$135,150.00|| |
|2/5/2014||Christopher Holden||CEO||Sell||3,000||$40.73||$122,190.00|| |
|12/4/2013||Christopher Holden||CEO||Sell||3,000||$46.45||$139,350.00|| |
|11/18/2013||Phillip Clendenin||EVP||Sell||3,000||$44.50||$133,500.00|| |
|11/11/2013||Claire Gulmi||CFO||Sell||48,380||$43.28||$2,093,886.40|| |
|10/25/2013||Thomas G Cigarran||Director||Sell||24,200||$42.99||$1,040,358.00|| |
|10/21/2013||Phillip A Clendenin||EVP||Sell||1,500||$43.00||$64,500.00|| |
|10/18/2013||David L Manning||EVP||Sell||15,000||$42.59||$638,850.00|| |
|10/10/2013||David Manning||EVP||Sell||14,726||$41.00||$603,766.00|| |
|10/10/2013||Kevin Delon Eastridge||CAO||Sell||7,819||$41.50||$324,488.50|| |
|10/2/2013||Christopher A Holden||CEO||Sell||3,000||$40.56||$121,680.00|| |
|9/9/2013||Christopher A Holden||CEO||Sell||5,000||$37.56||$187,800.00|| |
|8/22/2013||David Manning||EVP||Sell||19,600||$39.40||$772,240.00|| |
|8/14/2013||David Manning||EVP||Sell||2,000||$40.00||$80,000.00|| |
|7/31/2013||Claire M Gulmi||CFO||Sell||70,000||$39.08||$2,735,600.00|| |
|7/31/2013||Steven I Geringer||Director||Sell||6,000||$39.05||$234,300.00|| |
|7/29/2013||Christopher A Holden||CEO||Sell||48,233||$39.62||$1,910,991.46|| |
|7/26/2013||Kevin Delon Eastridge||CAO||Sell||20,000||$39.96||$799,200.00|| |
|7/17/2013||David L Manning||EVP||Sell||15,000||$39.50||$592,500.00|| |
|7/11/2013||David L Manning||EVP||Sell||15,000||$38.17||$572,550.00|| |
|5/23/2013||David L Manning||EVP||Sell||10,000||$36.02||$360,200.00|| |
|5/20/2013||David L Manning||EVP||Sell||13,941||$36.34||$506,615.94|| |
|5/16/2013||David L Manning||EVP||Sell||30,280||$35.83||$1,084,932.40|| |
|5/10/2013||David L Manning||EVP||Sell||10,000||$35.28||$352,800.00|| |
|5/7/2013||Kevin Delon Eastridge||CAO||Sell||12,500||$35.00||$437,500.00|| |
|3/12/2013||Phillip A Clendenin||EVP||Sell||5,000||$31.25||$156,250.00|| |
|3/11/2013||Billie Aileen Payne||VP||Sell||8,026||$30.80||$247,200.80|| |
|9/6/2012||David L Manning||EVP||Sell||13,408||$30.19||$404,787.52|| |
Headline Trends for Envision Healthcare Corp (NASDAQ:AMSG)
Latest Headlines for Envision Healthcare Corp (NASDAQ:AMSG)
Envision Healthcare Corp (AMSG) Chart for Friday, July, 21, 2017